While industry representatives welcomed the move to provide duty-free access to Indian goods, the exclusion of the CDSCO from the regulatory recognition framework is flagged as a concern and prompted calls for reconsideration.
from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/1kKgysP
via
MedTech sees trade upside in India–NZ FTA; missing regulatory recognition a concern
April 28, 2026
0
Tags